Expression of PI3K/p-AKT/p-mTOR in gastric carcinoma and its correlation with clinicopathologic characteristics

被引：0
|
作者：
Jieer, Ying
Qi, Xu
Liu Bixia
Cheng Xiangdong
机构：
[1] Zhejiang Canc Hosp, Dept Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Dept Abdominal Surg Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancerPrognostischer und prädiktiver Werte von p-Akt, EGFR und p-mTOR beim Mammakarzinom im Frühstadium
    Georgios Lazaridis
    Sofia Lambaki
    Georgia Karayannopoulou
    Anastasia G. Eleftheraki
    Irene Papaspirou
    Mattheos Bobos
    Ioannis Efstratiou
    George Pentheroudakis
    Nikolaos Zamboglou
    George Fountzilas
    Strahlentherapie und Onkologie, 2014, 190 (7) : 636 - 645
  • [12] Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer
    Chun, Sang Hoon
    Jung, Chan-Kwon
    Won, Hye Sung
    Kang, Jin-Hyoung
    Kim, Yeon-Sil
    Kim, Min-Sik
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (05): : 636 - 643
  • [13] PI3K/AKT/mTOR
    Umemura, Shigeki
    Goto, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S116 - S117
  • [14] 薄型子宫内膜PI3K、AKT、p-AKT的表达研究
    肖水秀
    乐爱文
    单莉莉
    黎雪茹
    戴晓云
    肖天慧
    卓蓉
    王中海
    河北医药, 2016, 38 (03) : 348 - 351
  • [15] Expression of Glut-1, HIF-1α, PI3K and p-Akt in a case of ceruminous adenoma
    Shen, Wan-Qin
    Cheng, Ke-Jia
    Bao, Yang-Yang
    Zhou, Shui-Hong
    Yao, Hong-Tian
    HEAD & NECK ONCOLOGY, 2012, 4
  • [16] Expression of PI3K/AKT/mTOR pathway in renal cell carcinoma metastases: Correlation with pathologic findings and survival
    Abou Youssif, Tamer M.
    Tanguay, Simon
    Alam-Fahmy, Mona
    Koumakpayi, Ismael H.
    Sircar, Kanishka
    JOURNAL OF UROLOGY, 2008, 179 (04): : 210 - 210
  • [17] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
    Zhou, Qian
    Lui, Vivian W. Y.
    Yeo, Winnie
    FUTURE ONCOLOGY, 2011, 7 (10) : 1149 - 1167
  • [18] Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
    Sun, Eun Jin
    Wankell, Miriam
    Palamuthusingam, Pranavan
    McFarlane, Craig
    Hebbard, Lionel
    BIOMEDICINES, 2021, 9 (11)
  • [19] PI3K/AKT/MTOR SIGNALING IN UROTHELIAL CARCINOMA AND ITS VALUE IN CANCER THERAPY
    Nawroth, R.
    Stellwagen, F.
    Stoehr, R.
    Gschwend, J. E.
    Hartmann, A.
    Retz, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 263 - 263
  • [20] Effect of Huazhuojiedu medicated serum on the proliferation and activation of hepatic stellate cells and the expression of PI3K and p-Akt in rats
    Kang, Liang
    Wang, Yangang
    Zhang, Mingxi
    Sun, Runxue
    Lou, Yingying
    Wang, Ying
    Li, Diangui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (10): : 3280 - 3288
12345